当前位置：
X-MOL 学术
›
Mult. Scler. J.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis
Multiple Sclerosis Journal ( IF 5.8 ) Pub Date : 2024-02-22 , DOI: 10.1177/13524585241231655 Merve Bahar Ercan 1 , Belgin Kocer 1 , Taylan Altiparmak 1 , Ilker Arslan 1
中文翻译：
复发缓解型多发性硬化症患者严重早发那他珠单抗相关 PML-IRIS 对派姆单抗的反应
更新日期：2024-02-22
Multiple Sclerosis Journal ( IF 5.8 ) Pub Date : 2024-02-22 , DOI: 10.1177/13524585241231655 Merve Bahar Ercan 1 , Belgin Kocer 1 , Taylan Altiparmak 1 , Ilker Arslan 1
Affiliation
中文翻译：
复发缓解型多发性硬化症患者严重早发那他珠单抗相关 PML-IRIS 对派姆单抗的反应
京公网安备 11010802027423号